Trial Profile
A phase IIa, single-center, randomized, observer-blind, placebo- and reference-controlled proof of concept study with intraindividual comparison of treatments to investigate the safety and antipsoriatic efficacy of topical valrubicin formulations in a psoriasis plaque test.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Nov 2011
Price :
$35
*
At a glance
- Drugs Valrubicin (Primary) ; Betamethasone valerate; Calcipotriol
- Indications Plaque psoriasis
- Focus Therapeutic Use
- 21 Jun 2011 New trial record